The evolutionary landscape of antifolate resistance in Plasmodium falciparum

Journal of Genetics

Volumn 90, Issue 2, 2011, Pages 187-190

  Costanzo, Marna S ^a   Hartl, Daniel L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

antifolates; chlorcycloguanil; dihydrofolate reductase; drug resistance; malaria; pyrimethamine

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; PROTOZOAL PROTEIN;

ADAPTATION; ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; MALARIA FALCIPARUM; MOLECULAR EVOLUTION; MUTATION; PLASMODIUM FALCIPARUM;

ADAPTATION, BIOLOGICAL; ANIMALS; DRUG RESISTANCE; EVOLUTION, MOLECULAR; FOLIC ACID ANTAGONISTS; HUMANS; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE;

ESCHERICHIA COLI; PLASMODIUM FALCIPARUM; SACCHAROMYCES CEREVISIAE;

EID: 80053133668     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-011-0072-z     Document Type: Article

References (28)

1. Abdel-Muhsin A. A., Mackinnon M. J., Ali E., Nassir E. A., Suleiman S., Ahmed S. et al. 2004 Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in eastern Sudan. J. Infect. Dis. 189, 1239-1244.
2. Agur Z. and Slobodkin L. 1986 Environmental fluctuations - how do they affect the topography of the adaptive landscape. J. Genet. 65, 45-54.
3. Andersson D. I. 2006 The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9, 461-465.
4. Brown K. M., Costanzo M. S., Xu W., Roy S., Lozovsky E. R. and Hartl D. L. 2010 Compensatory mutations restore fitness during the evolution of dihydrofolate reductase. Mol. Biol. Evol. 27, 2682-2690.
5. Chusacultanachai S., Thiensathit P., Tarnchompoo B., Sirawaraporn W. and Yuthavong Y. 2002 Novel antifolate resistant mutations of Plasmodium falciparum dihydrofolate reductase selected in Escherichia coli. Mol. Biochem. Parasitol. 120, 61-72.
6. Costanzo M. S., Brown K. M. and D. L Hartl 2011 Fitness trade-offs in the evolution of drug resistance in dihydrofolate reductase in Plasmodium falcipaurm. PLoS ONE 6, e19636.
7. Cowman A. F., Morry M. J., Biggs B. A., Cross G. A. and Foote S. J. 1988 Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA85, 9109-9113.
8. Diggens S. M., Gutteridge W. E. and Trigg P. I. 1970 Altered dihydrofolate reductase associated with a pyrimethamine-resistant Plasmodium berghei berghei produced in a single step. Nature228, 579-580.
9. Gregson A. and Plowe C. V. 2005 Mechanisms of resistance of malaria parasites to antifolates. Pharmacol. Rev. 57, 117-145.
10. Kublin J. G., Fraction K. Dzinjalamala, Kamwendo D. D., Malkin E. M., Cortese J. F. et al. 2002 Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185, 380-388.
11. Lozovsky E. R., Chookajorn T., Brown K. M., Imwong M., Shaw P. J., Kamchonwongpaisan S. et al. 2009 Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl. Acad. Sci. USA106, 12025-12030.
12. Mita T., Tanabe K., Takahashi N., Culleton R., Ndounga M., Dzodzomenyo M. et al. 2008 Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa. J. Antimicrob. Chemother. 68, 413-415.
13. Nzila-Mounda A., Mberu E. K., Sibley C. H., Plowe C. V., Winstanley P. A. and Watkins W. M. 1998 Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. 42, 164-169.
14. Nzila-Mounda A., Mberu E. K., Sibley C. H., Plowe C. V., Winstanley P. A. and Watkins W. M. 1998b Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrob. Agents Chemother. 42, 164-169.
15. Peterson D. S., Walliker D. and Wellems T. E. 1988 Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA85, 9114-9118.
16. Rastelli G., Sirawaraporn W., Sompornpisut P., Vilaivan T., Kamchonwongpaisan S., Quarrell R. et al. 2000 Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance. Bioorg. Med. Chem. 8, 1117-1128.
17. Salverda M. L. M., de Visser J. A. G. M. and Barlow M. 2010 Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol. Rev. 34, 1015-1036.
18. Salverda M. L. M., Merijn L. M., Salverda E., Dellus F. A., Gorter A. J. M., Debets J. et al. 2011 Initial mutations direct alternative pathways of protein evolution. PLoS Genet. 7, e1001321.
19. Sandefur C. I., Wooden J. M., Quaye I. K., Sirawaraporn W. and Sibley C. H. 2007 Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro. Mol. Biochem. Parasitol. 154, 1-5.
20. Sibley C. H., Hyde J. E., Sims P. F. G., Plowe C. V., Kublin J. G., Mberu E. K. et al. 2001 Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17, 582-588.
21. Sirawaraporn W., Sathitkul T., Sirawaraporn R., Yuthavong Y. and Santi D. 1997 Antifolate-resistant mutants of Plasmodium falciparum dihydrofolatereductase. Proc. Natl. Acad. Sci. USA94, 1124-1129.
22. Sirawaraporn W., Sirawaraporn R., Cowman A. F., Yuthavong Y. and Santi D. V. 1990 Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum. Biochemistry29, 10779-10785.
23. Thompson P. E. and Bayles A. 1968 Reciprocal cross resistance between cycloguanil hydrochloride and pyrimethamine in Plasmodium berghei infections in mice. J. Parasitol. 54, 588-593.
24. Walliker D., Hunt P. and Babiker H. 2005 Fitness of drug-resistant malaria parasites. Acta Tropica94, 251-259.
25. Wang P., Lee C., Bayoumi R., Djimde A., Doumbo O., Swedberg G. et al. 1997 Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89, 161-177.
26. Weinreich D. M., Delaney N. F., DePristo M. A. and Hartl D. L. 2006 Darwinian evolution can follow only very few mutational paths to fitter proteins. Science312, 111-114.
27. Wooden J. M., Hartwell L. H., Vasquez B. and Hopkins Sibley C. 1997 Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum. Mol. Biochem. Parasitol. 85, 25-40.
28. Zhou Z., Griffing S. M., de Oliveira A. M., McCollum A. M., Quezada W. M., Arrospide N. et al. 2008 Decline in sulfadoxine-pyrimethamine-resistant alleles after change in drug policy in the amazon region of Peru. Antimicrob. Agents Chemother. 52, 739-741.